Nxera Pharma Webinar Presentation for FY2024 Financial Results
(TSE:4565.T), Tokyo, Japan and Cambridge, UK, 23 January 2025 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2024 on Friday, 14 February 2025. The Company will host a live webinar presentation with Chris Cargill, President and CEO, Hironoshin Nomura, CFO, […]